4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-18-064099
10% owner bought 90,742 shares at an average $24.08 ($2,184,960)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals (Europe) Ltd 10% owner | 2018-12-21 | Purchase | +22,742 | $22.58 | $513,478 | 5,272,742 | D |
| Vertex Pharmaceuticals (Europe) Ltd 10% owner | 2018-12-24 | Purchase | +2,603 | $22.91 | $59,647 | 5,275,345 | D |
| Vertex Pharmaceuticals (Europe) Ltd 10% owner | 2018-12-24 | Purchase | +11,742 | $23.18 | $272,140 | 5,287,087 | D |
| Vertex Pharmaceuticals (Europe) Ltd 10% owner | 2018-12-24 | Purchase | +53,655 | $24.97 | $1,339,696 | 5,340,742 | D |
| Open-market purchases · 90,742 sh · avg $24.08 · $2,184,960 | |||||||
Loading xslF345X03/doc4.xml…